Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trabectedin + Olaparib vs Trabectedin in Advanced STS
NCT03838744Phase 2Completed
- Sponsor
- Italian Sarcoma Group
- Start
- May 2020
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of olaparib in soft tissue sarcoma (STS), sponsored by Italian Sarcoma Group. Started May 2020; status: completed.
02
Drugs
olaparib
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT03838744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03838744.